SIOC 中文
ACS
Adv search

Acta Chimica Sinica >

0 1 - 1

DOI: https://doi.org/10.6023/A26070255

Article

4-Methoxycinnamaldehyde Oxalyl Dihydrazone Copper Complex for Antitumor Chemodynamic Therapy

  • Chen Xi ,
  • Lai Xinjie ,
  • Liu Fangyi ,
  • Liu Siqi ,
  • Wu Gaorong ,
  • Huang Fuping ,
  • Hong Zhaoguo
Expand
  • aCollege of Pharmacy, Gannan Medical University, Ganzhou 341000;
    bState Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004

Received date: 2026-07-20

  Online published: 2026-08-26

Supported by

Early-Career Young Scientists and Technologists Project of Jiangxi Province (20244BCE52222), Jiangxi Provincial Natural Science Foundation (20252BAC200240) and the Start-up Funds of Gannan Medical University (QD202405).

Fold

Abstract

The development of structurally well-defined metal complexes with Fenton-like catalytic activity is of great significance for the multifunctional design and efficacy-toxicity optimization of chemodynamic therapy (CDT) agents. The complex crystallizes in triclinic space group P ī with a distorted tetrahedral geometry around each Cu(I). In this study, 4-methoxycinnamaldehyde and oxalyl dihydrazide were employed as starting materials to synthesize the 4-methoxycinnamaldehyde oxalyl dihydrazone ligand (MC-OD) via a condensation reaction. Subsequent coordination with triphenylphosphine and copper(II) nitrate afforded a dinuclear copper(I) complex (MC-OD-Cu). The molecular structure of the complex was unambiguously characterized by single-crystal X-ray diffraction, and its physicochemical stability as well as Fenton-like catalytic performance were systematically evaluated. XPS and Auger spectroscopy confirmed the Cu(I) valence state, while MB degradation and EPR experiments verified the generation of •OH. The EPR spectrum exhibited a typical 1:2:2:1 quartet signal, and the UV-vis absorbance of methylene blue at 655 nm decreased sharply after reaction. In vitro cellular assays demonstrated that the complex efficiently catalyzes the decomposition of intracellular hydrogen peroxide to generate substantial reactive oxygen species (ROS), thereby triggering oxidative stress damage in tumor cells and subsequently inducing apoptosis. The complex showed potent cytotoxicity against HeLa cells (IC₅₀ = 0.98 μmol/L) with moderate selectivity over normal cells. Specifically, the selectivity index was approximately 3-4, based on IC₅₀ values against normal cell lines such as HCV-29, HL-7702 and W138. Flow cytometry indicated concentration-dependent apoptosis induction, even at near-IC₅₀ concentrations. Notably, the complex exhibited significant antiproliferative activity against tumor cells. Collectively, MC-OD-Cu represents a promising class of novel chemodynamic antitumor agents. This study provides an experimental basis and theoretical basis for the application of cinnamaldehyde-derived metal complexes in tumor chemodynamic therapy. The single crystals of the complex were obtained by slow volatilization of a saturated mixed solvent of methanol and dichloromethane at room temperature after filtration and left undisturbed for several days.

Key words： cinnamaldehyde derivatives; copper-based metal complexes; chemodynamic therapy; hydroxyl radicals; antitumor

Cite this article

Chen Xi , Lai Xinjie , Liu Fangyi , Liu Siqi , Wu Gaorong , Huang Fuping , Hong Zhaoguo . 4-Methoxycinnamaldehyde Oxalyl Dihydrazone Copper Complex for Antitumor Chemodynamic Therapy[J]. Acta Chimica Sinica, 0 : 1 -1 . DOI: 10.6023/A26070255

References

[1] (a) Wang, D.; Ji, L.; Li, Y.; Xu, M.; Wang, H.; Brovelli, S.; Qiao, Z. Y.; Zhang, J. T.; Li, Y. D. Nat. Nanotechnol. 2025, 20, 1098. (b) Yang, K.; Chen, Q.; Chen, J.; Geng, L. F.; Ma, M. X.; Gu, Y. Q.; Choudhary, M. I.; Liang, H.; Chen, Z. F. J. Med. Chem. 2025, 68, 7137. (c) Zhang, R. F.; Jiang, B.; Fan, K. L.; Gao, L. Z.; Yan, X. Y. Nat. Rev. Bioeng. 2024, 2, 849.
[2] (a) Shi, X.; Zhou, X.; Xiao, B.; Xu, H.; Zhang, W.; Hu, H.; Shao, S.; Zhou, Z.; Shen, Y.; Xu, X.; Tang, J. Chin. Chem. Lett. 2025, 36, 110178. (b) Jia, C. Y.; Guo, Y. X.; Wu, F. G. Small 2022, 18, 2103868. (c) Li, S. L.; Chu, X.; Dong, H. L.; Hou, H. Y.; Liu, Y. Coord. Chem. Rev. 2023, 479, 215004.
[3] (a) Li, J. Q.; Huang, Y. Q.; Ding, G. C.; Zhang, R.; Liu, X. F.; Fan, Q. L.; Huang, W. Acta Chim. Sinica 2025, 83, 1324. (in Chinese) 李佳启,黄艳琴,丁桂策,张瑞,刘兴奋,范曲立,黄维,化学学报, 2025, 83, 1324. (b) Peng, J Y.; Liu, H. Y.; Tang, X. F.; Cui, X. Y.; Li, S. B.; Han, X. J. Chin. J. Chem. 2026, 44, 291.
[4] (a) Wei, W. Y.; Kang, H. F.; Lian C. X.; Liu, J. W.; Lin, J. W.; Yang, J. W.; Xu, Z. M. C.; Wang, Z. Q.; Yin, M. Z.; Dai, H. L.; Biomater. Adv. 2025, 166, 214046. (b) Li, C. Y.; Huang, Y.; Ding, Z. Y.; Zhao, Y.; Tang, X. L.; Han, Y. C.; Zhao, G.; ACS Appl. Mater. Interfaces 2025, 17, 49148. (c) Wang, C. B.; Xue, F. F.; Wang, M. X.; An, L.; Wu, D.; Tian, Q. W. ACS Appl. Mater. Interfaces 2022, 14, 38604.
[5] Zhang C.; Bu W. B.; Ni D. L.; Zhang S. J.; Li Q.; Yao Z. W.; Zhang J. W.; Yao H. L.; Wang Z.; Shi J. L. Angew. Chem. Int.Ed. 2016, 55, 2101.
[6] (a) Koo, S.; Kim, Y. G.; Lee, N.; Hyeon, T.; Kim, D. Nanoscale 2023, 15, 13498. (b) Sun, B.; Zhao, N.; Xu, X.; Jiang, L.; Lu, F.; Fan, Q. L.; Huang, W. Chin. J. Inorg. Chem. 2023, 39, 671. (in Chinese) 孙博,赵宁,徐欣,姜来,陆峰,范曲立,黄维, 无机化学学报, 2023, 39, 671.
[7] (a) Shu, Z.; Guo, W.; Shang, Y.; Yang, Y.; Yang, P. Bioorg. Chem. 2025, 161, 108545. (b) Cao, Y.; Cao, C.; Jiao, Y.; Hao, H.; Gao, D.; Gao, Y.; Yao, K.; Wu, R.; Liu,Y. Biomater. Sci. 2026, 14, 1462. (c) Fan, C.; Zhou, Y.; Mei, Y.; Wu, K.; Wang, M.; Chen, L.; Liu, H.; Dong, Z.; Xu, L. Nano Today 2026, 67, 102935.
[8] (a) Luo, B.; Cheng, L. G.; Hong, Z. G.; You,X.; Huang, F. P.; Bian, H. D.; Zhang, L. L.; Zhao, S. L.; Chem. Commun. 2021, 57, 6046. (b) Hong, Z. G.; You, X.; Zhong, J. J.; Yao, D.; Bian, H. D.; Zhao, S. L.; Zhang, L. L.; Liang; H.; Huang, F. P. Inorg. Chem. Front. 2023, 10, 4045.
[9] (a) Ka, H.; Park, H. J.; Jung, H. J.; Choi, J. W.; Cho, K. S.; Ha, J.; Lee, K. T. Cancer Lett. 2003, 196, 143. (b) Lu, N. N.; Xi, L. C.; Zha, Z. S.; Wang, Y. H.; Han, X. H.; Ge, Z. S. Biomater. Sci. 2021, 9, 4613. (c) Noh, J.; Kwon, B.; Han, E.; Park, M.; Yang, W.; Cho, W.; Yoo, W.; Khang, G.; Lee, D. Nat. Commun. 2015, 6, 6907.
[10] (a) Dai, W. B.; Deng, Y. Y.; Chen, X. H.; Huang, Y.; Hu, H. T.; Jin, Q.; Tang, Z.; Ji, J. Biomaterials 2022, 290, 121854. (b) Bai, Y.; Pan, Y. J.; An, N.; Zhang, H. T.; Wang, C.; Tian, W.; Huang, T. Chin. Chem. Lett. 2023, 34, 107552.
[11] (a) Hong, Z.-G.; Zhong, J. J.; Ding, D. D.; Gong, S. H.; Huang, S. D.; Zhong, Q. Q.; Ding, D. D.; Bian, H. D.; Liang, H.; Huang, F. P. J. Mater. Chem. B 2022, 10, 5086. (b) Hong, Z. G.; Zhong, J. J.; Ding, D. D.; Gong, S. H.; Zhang, L. L.; Zhao, S. L.; Shen, X. C.; Liang, H.; Huang, F. P. Dalton Trans. 2023, 52, 6187.
[12] (a) Sheldrick, G. M. Acta Crystallogr. Sect. A: Found. Adv. 2015, A71, 3. (b) Sheldrick,G. M. Acta Crystallogr. Sect. C: Struct. Chem. 2015, C71, 3.
[13] Spek A. L. Acta Crystallogr C, 2015, 71, 9.
Options
Outlines

/

〈 〉